Author | Jared Kaltwasser


Secukinumab Has High Retention Rate in Real-World Psoriatic Arthritis Study

August 08, 2020


New real-world data shows 64% of patients with psoriatic arthritis who had previously been on a biologic stayed on secukinumab for the duration of the study.

Reorganization of Sickle Cell Care Leads to Dramatic Drop in Hospitalizations

August 07, 2020


Yale New Haven Hospital’s reorganization of its sickle cell disease program led patients to report feeling better off and needing fewer hospitalizations. However, the change left some with the disease still feeling unsatisfied.

Study Describes Ozanimod’s Mechanism of Action in Relapsing MS

August 06, 2020


A new analysis offers insights into how ozanimod works in patients with relapsing multiple sclerosis, as well as the impact of higher dosage.

Analysis Finds White, African American Patients Have Similar Access to Optimal MM Treatments

August 01, 2020


New research suggests white and African American patients have similar rates of access to new treatments for multiple myeloma.